A detailed history of Arizona State Retirement System transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Arizona State Retirement System holds 12,630 shares of SRRK stock, worth $558,498. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,630
Previous 11,988 5.36%
Holding current value
$558,498
Previous $99,000 2.02%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$7.63 - $9.71 $4,898 - $6,233
642 Added 5.36%
12,630 $101,000
Q2 2024

Aug 05, 2024

BUY
$7.84 - $16.79 $8,490 - $18,183
1,083 Added 9.93%
11,988 $99,000
Q1 2024

May 07, 2024

SELL
$13.2 - $17.76 $38,161 - $51,344
-2,891 Reduced 20.96%
10,905 $193,000
Q4 2023

Jan 24, 2024

BUY
$6.52 - $20.32 $19,403 - $60,472
2,976 Added 27.5%
13,796 $259,000
Q3 2023

Nov 06, 2023

BUY
$6.02 - $7.76 $3,605 - $4,648
599 Added 5.86%
10,820 $76,000
Q2 2023

Aug 01, 2023

SELL
$5.79 - $9.11 $5,824 - $9,164
-1,006 Reduced 8.96%
10,221 $77,000
Q1 2023

Apr 27, 2023

BUY
$7.36 - $12.72 $2,200 - $3,803
299 Added 2.74%
11,227 $89,000
Q4 2022

Feb 07, 2023

BUY
$7.02 - $9.76 $2,850 - $3,962
406 Added 3.86%
10,928 $98,000
Q3 2022

Nov 07, 2022

BUY
$5.33 - $11.3 $56,082 - $118,898
10,522 New
10,522 $73,000
Q4 2021

Feb 04, 2022

SELL
$24.14 - $35.18 $147,085 - $214,351
-6,093 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$27.38 - $42.21 $166,826 - $257,185
6,093 New
6,093 $201,000
Q2 2021

Aug 02, 2021

SELL
$26.34 - $46.62 $180,560 - $319,580
-6,855 Closed
0 $0
Q1 2021

May 06, 2021

BUY
$45.96 - $68.02 $36,354 - $53,803
791 Added 13.04%
6,855 $347,000
Q4 2020

Jan 28, 2021

BUY
$13.72 - $51.57 $83,198 - $312,720
6,064 New
6,064 $294,000

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $2.28B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.